These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11245453)

  • 1. The pharmacological phenotype of combined multidrug-resistance mdr1a/1b- and mrp1-deficient mice.
    Johnson DR; Finch RA; Lin ZP; Zeiss CJ; Sartorelli AC
    Cancer Res; 2001 Feb; 61(4):1469-76. PubMed ID: 11245453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of the importance of multidrug resistance-associated protein 1 and P-glycoprotein to drug sensitivity in immortalized mouse embryonic fibroblasts.
    Lin ZP; Johnson DR; Finch RA; Belinsky MG; Kruh GD; Sartorelli AC
    Mol Cancer Ther; 2002 Oct; 1(12):1105-14. PubMed ID: 12481434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance.
    Allen JD; Brinkhuis RF; van Deemter L; Wijnholds J; Schinkel AH
    Cancer Res; 2000 Oct; 60(20):5761-6. PubMed ID: 11059771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related differences in vincristine toxicity and biodistribution in wild-type and transporter-deficient mice.
    Muramatsu T; Johnson DR; Finch RA; Johnson LK; Leffert JJ; Lin ZP; Pizzorno G; Sartorelli AC
    Oncol Res; 2004; 14(7-8):331-43. PubMed ID: 15301424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-glycoprotein and Mrp1 collectively protect the bone marrow from vincristine-induced toxicity in vivo.
    van Tellingen O; Buckle T; Jonker JW; van der Valk MA; Beijnen JH
    Br J Cancer; 2003 Nov; 89(9):1776-82. PubMed ID: 14583783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of chemosensitizers on resistance mechanisms in daunorubicin-resistant Ehrlich ascites tumour cells.
    Nielsen D; Eriksen J; Maare C; Friche E; Skovsgaard T
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):453-60. PubMed ID: 12107549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein.
    Allen JD; Van Dort SC; Buitelaar M; van Tellingen O; Schinkel AH
    Cancer Res; 2003 Mar; 63(6):1339-44. PubMed ID: 12649196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient mice.
    van der Deen M; Timens W; Timmer-Bosscha H; van der Strate BW; Scheper RJ; Postma DS; de Vries EG; Kerstjens HA
    Respir Res; 2007 Jul; 8(1):49. PubMed ID: 17617921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of P-glycoprotein and multidrug resistance associated protein in Ehrlich ascites tumor cells after fractionated irradiation.
    Nielsen D; Maare C; Eriksen J; Litman T; Skovsgaard T
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1050-7. PubMed ID: 11704330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents.
    Zeng H; Bain LJ; Belinsky MG; Kruh GD
    Cancer Res; 1999 Dec; 59(23):5964-7. PubMed ID: 10606242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.
    Stam RW; van den Heuvel-Eibrink MM; den Boer ML; Ebus ME; Janka-Schaub GE; Allen JD; Pieters R
    Leukemia; 2004 Jan; 18(1):78-83. PubMed ID: 14574327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent lack of Mrp1-mediated efflux at the luminal side of mouse blood-brain barrier endothelial cells.
    Cisternino S; Rousselle C; Lorico A; Rappa G; Scherrmann JM
    Pharm Res; 2003 Jun; 20(6):904-9. PubMed ID: 12817896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicokinetic and genomic analysis of chronic arsenic exposure in multidrug-resistance mdr1a/1b(-/-) double knockout mice.
    Xie Y; Liu J; Liu Y; Klaassen CD; Waalkes MP
    Mol Cell Biochem; 2004 Jan; 255(1-2):11-8. PubMed ID: 14971641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the binding of the tricyclic isoxazole photoaffinity label LY475776 to multidrug resistance associated protein 1 (MRP1) orthologs and several ATP- binding cassette (ABC) drug transporters.
    Dantzig AH; Shepard RL; Pratt SE; Tabas LB; Lander PA; Ma L; Paul DC; Williams DC; Peng SB; Slapak CA; Godinot N; Perry WL
    Biochem Pharmacol; 2004 Mar; 67(6):1111-21. PubMed ID: 15006547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1.
    Renes J; de Vries EG; Nienhuis EF; Jansen PL; Müller M
    Br J Pharmacol; 1999 Feb; 126(3):681-8. PubMed ID: 10188979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes.
    Declèves X; Regina A; Laplanche JL; Roux F; Boval B; Launay JM; Scherrmann JM
    J Neurosci Res; 2000 Jun; 60(5):594-601. PubMed ID: 10820430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential involvement of multidrug resistance-associated protein 1 and P-glycoprotein in tissue distribution and excretion of grepafloxacin in mice.
    Sasabe H; Kato Y; Suzuki T; Itose M; Miyamoto G; Sugiyama Y
    J Pharmacol Exp Ther; 2004 Aug; 310(2):648-55. PubMed ID: 15131241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells.
    Chen GK; Durán GE; Mangili A; Beketic-Oreskovic L; Sikic BI
    Br J Cancer; 2000 Oct; 83(7):892-8. PubMed ID: 10970691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.
    Schinkel AH; Mayer U; Wagenaar E; Mol CA; van Deemter L; Smit JJ; van der Valk MA; Voordouw AC; Spits H; van Tellingen O; Zijlmans JM; Fibbe WE; Borst P
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):4028-33. PubMed ID: 9108099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.